Status:
NOT_YET_RECRUITING
Imaging and Treatment Planning for Cardiac Radioablation
Lead Sponsor:
Stewart Gaede
Conditions:
Ventricular Tachycardia, Monomorphic
Ventricular Tachycardia (V-Tach)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cardiac radioablation is a new treatment for ventricular tachycardia (VT), which uses beams of radiation to treat heart scar that causes VT. To identify the scar areas, magnetic resonance imaging (MRI...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Ischemic cardiomyopathy with monomorphic VT
- Referred by cardiologists
- 18 years of age or older Exclusion Criteria
- • Polymorphic ventricular tachycardia
- Ventricular fibrillation
- Pregnant or breastfeeding or planning to become pregnant or breastfeed during the study
- Estimated glomerular filtration rate ≤ 30 mL/min/1.73m2
- Previous allergic reaction to CT contrast agent Note that participants with contraindications for MRI can still be enrolled in this study but will not undergo MRI parts of this protocol.
Exclusion
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06938074
Start Date
November 1 2025
End Date
September 1 2026
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre Research Inc
London, Ontario, Canada